Period prevalence | (n=1752) | (n=1521) | (n=1172) |
With no effects on daily living | 48 (2.7%) | 72 (4.7%) | 54 (4.6%) |
With effects on daily living | 28 (1.6%) | 34 (2.2%) | 60 (5.1%) |
All | 76 (4.3%) | 106 (6.9%) | 114 (9.7%) |
| [3.5 to 5.4] | [5.8 to 8.4] | [8.2 to 11.6] |
Corrected for differential attrition | 77 (4.3%) | 110 (7.2%) | 121 (10.3%) |
| [3.5 to 5.4] | [6.0 to 8.6] | [8.7 to 12.2] |
Specific problem categories | (n=76) | (n=106) | (n=114) |
Asthma | 13 (17.1%) | 23 (21.7%) | 28 (24.6%) |
Eczema | 22 (28.9%) | 15 (14.2%) | 5 (4.4%) |
Other allergies | 0 | 4 (3.8%) | 6 (5.3%) |
Congenital abnormalities | 32 (42.0%) | 42 (39.6%) | 32 (28.1%) |
Developmental delay | 1 (1.3%) | 7 (6.6%) | 26 (22.8%) |
Hearing loss | 2 (2.6%) | 4 (3.8%) | 3 (2.6%) |
Other | 6 (8.1%) | 11 (10.3%) | 14 (12.2%) |